First use of CRISPR against cancer in patients clears early safety hurdles

Wednesday, November 6, 2019

STAT / The Associated Press – The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it’s too soon to know if it will improve survival.